Sangamo Therapeutics Aktie
0,49
EUR
-0,01
EUR
-1,74
%
0,56
USD
-0,01
USD
-2,44
%
Werbung
Sangamo Therapeutics Aktie Analyse
| 01.11.16 | Sangamo Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
| 11.11.08 | Sangamo Therapeutics neutral | Merriman Curhan Ford & Co |
Werbung
Werbung